Jonathan V Mui

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors vs. Dipeptidyl Peptidase-4 (DPP4) Inhibitors for New-Onset Dementia: A Propensity Score-Matched Population-Based Study With Competing Risk Analysis

Jonathan V Mui, Jiandong Zhou, Sharen Lee et al. · Frontiers in Cardiovascular Medicine · 2021 · 112 citations · Full text

Comparing sodium-glucose cotransporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors on new-onset depression: a propensity score-matched study in Hong Kong

Jonathan V Mui, Lifang Li, Oscar Hou In Chou et al. · Acta Diabetologica · 2023 · 17 citations · Full text

Lower risks of new-onset acute pancreatitis and pancreatic cancer in sodium glucose cotransporter 2 (SGLT2) inhibitors compared to dipeptidyl peptidase-4 (DPP4) inhibitors: A propensity score-matched study with competing risk analysis

Oscar Hou In Chou, Jiandong Zhou, Jonathan V Mui et al. · Diabetes Epidemiology and Management · 2022 · 16 citations · Full text